142 related articles for article (PubMed ID: 3164537)
1. [Preoperative chemotherapy of locally disseminated cancer of the urinary bladder using methotrexate, vinblastine, platidiam and farmorubicin].
Matveev BP; Gadzhiev NG; Chevelidze ShG
Urol Nefrol (Mosk); 1988; (2):38-41. PubMed ID: 3164537
[No Abstract] [Full Text] [Related]
2. [Possibilities and limits of chemotherapy in multi-modality treatment of urinary bladder cancer].
Rüther U; Rassweiler J; Lüthgens M; Bub P; Jipp P; Eisenberger F
Verh Dtsch Ges Inn Med; 1989; 95():544-52. PubMed ID: 2603494
[No Abstract] [Full Text] [Related]
3. Neo-adjuvant intra-arterial chemotherapy in locally advanced bladder cancer.
Chechile G; Montie J; Pontes JE; Bukowski RM
Prog Clin Biol Res; 1990; 353():153-61. PubMed ID: 2217413
[No Abstract] [Full Text] [Related]
4. Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
Fair WR; Scher H; Herr H; Morse M; Sogani P; Bosi G; Dershaw D; Reuter V; Curley T
Semin Urol; 1990 Aug; 8(3):190-6. PubMed ID: 2399387
[No Abstract] [Full Text] [Related]
5. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
Koch MO; Coussens D
Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
[No Abstract] [Full Text] [Related]
6. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).
Lehmann J; Retz M; Wiemers C; Beck J; Thüroff J; Weining C; Albers P; Frohneberg D; Becker T; Funke PJ; Walz P; Langbein S; Reiher F; Schiller M; Miller K; Roth S; Kälble T; Sternberg D; Wellek S; Stöckle M;
J Clin Oncol; 2005 Aug; 23(22):4963-74. PubMed ID: 15939920
[TBL] [Abstract][Full Text] [Related]
7. [Systemic chemotherapy in advanced bladder cancer. New aspects].
Jakse G
Wien Klin Wochenschr; 1987 Jan; 99(2):54-7. PubMed ID: 3564487
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response.
Splinter TA; Denis L; Scher HI; Schröder FH; Dalesio O
Prog Clin Biol Res; 1989; 303():541-7. PubMed ID: 2675011
[No Abstract] [Full Text] [Related]
9. Neo-adjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) for infiltrating bladder cancer: initial results in Italy.
Sternberg CN
Prog Clin Biol Res; 1990; 353():143-52. PubMed ID: 2217412
[No Abstract] [Full Text] [Related]
10. Treatment of high-stage bladder cancer: case for adjunctive chemotherapy.
Walther PJ
Semin Urol; 1993 May; 11(2):69-73. PubMed ID: 8362122
[No Abstract] [Full Text] [Related]
11. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
Lehmann J; Franzaring L; Thüroff J; Wellek S; Stöckle M
BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326
[TBL] [Abstract][Full Text] [Related]
12. M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.
Scher H; Herr H; Sternberg C; Fair W; Bosl G; Morse M; Sogani P; Watson R; Darshaw D; Reuter V
Prog Clin Biol Res; 1990; 353():179-86. PubMed ID: 2217417
[No Abstract] [Full Text] [Related]
13. Successful treatment of metastatic small cell carcinoma of the bladder with methotrexate, vinblastine, doxorubicin and cisplatin therapy.
Cheng DL; Unger P; Forscher CA; Fine EM
J Urol; 1995 Feb; 153(2):417-9. PubMed ID: 7815604
[TBL] [Abstract][Full Text] [Related]
14. Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
Bajorin DF
J Clin Oncol; 2001 Sep; 19(18 Suppl):17S-20S. PubMed ID: 11560966
[No Abstract] [Full Text] [Related]
15. Adjunctive adjuvant or neoadjuvant chemotherapy for locally advanced bladder cancer: a critical appraisal of the present status.
Walther PJ
Semin Urol; 1993 Nov; 11(4):227-34. PubMed ID: 8290828
[No Abstract] [Full Text] [Related]
16. Chemotherapy for bladder cancer.
Muñoz A; Barceló JR; López-Vivanco G
N Engl J Med; 2003 Dec; 349(23):2272-3; author reply 2272-3. PubMed ID: 14657442
[No Abstract] [Full Text] [Related]
17. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
Stöckle M; Meyenburg W; Wellek S; Voges GE; Rossmann M; Gertenbach U; Thüroff JW; Huber C; Hohenfellner R
J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
[TBL] [Abstract][Full Text] [Related]
18. Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy.
Sternberg CN; Yagoda A; Scher HI; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Bosl G; Watson RC; Hollander PS
Prog Clin Biol Res; 1988; 260():551-5. PubMed ID: 3283770
[No Abstract] [Full Text] [Related]
19. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?
Hall RR
Acta Urol Belg; 1996 May; 64(2):39-42. PubMed ID: 8701809
[No Abstract] [Full Text] [Related]
[Next] [New Search]